The spectrum of isolates among febrile neutropenic children in our hematology clinic appears to be gram positive pathogens which are the most common agents. Therefore the, documentation of the flora in each unit could help to decide appropriate empirical therapy which is life saving.
Neutropenia is one of the most common complications in children with cancer, and it is the most important parameter to determine infection risk. In neutropenic patients the signs and symptoms could be scarce and in occasions fever could be the only symptom 1 . Life threatening complications due to bacterial infections have been reported in 3-10% of all febril neutropenic episodes 2 .
Recent studies have found that 29-60% of neutropenic patients who become febrile have bacterial infections, of which 16-25% have bacteremias and gram (+) bacteremia has increased up to 60-70% of all microroganisms identified 3, 4 . Several studies suggest that a causative agent could not be documented in almost two-thirds of infectious episodes 5 . Presumably because immediately administration of empirical therapy masks documentation of infection.
The selection of empirical therapy should be based on a variety of factors such as a patient's infectious risk, potential sites, causative organisms and sensitivity of those organism to antibiotics 6 . In addition, individual centers should aim to describe the epidemiology of bacteremia to guide empiric antibiotic treatment among children with neutropenia. We aimed to determine the infection focus, causative organisms and effeciency of antibiotic treatment in our pediatric hematology clinic.
Material and Methods
In total, 48 leukemic children admitted to Pediatric Hematology Clinic of Harran University Faculty of Medicine between January 2008-June 2010 were evaluated in this study. Sixteen episodes were excluded from the study. These episodes had no complete clinical and laboratory evaluation. A hundred thirty six febrile episodes were anlaysed retrospectively. Neutropenia was defined as an absolute neutrophil count of < 500 cells/mm³ or a count of < 1000 cells/mm³ with a predicted decrease to < 500 cells/mm³. Fever was defined as a single tympanic temperature ≥38.3 ºC or a temperature of ≥38ºC at least 1 hour 7 . A blood culture was considered to be contaminated if coagulase-negative staphylococci, micrococcus species, corynebacterium species in a single bottle and were excluded from this analysis. Patients were included more than once in the analysis for separate episodes of bacteremia 8 . A urine culture was considered contaminated when it had a bacterial count greater than 100,000 colonies/ml 9 .
Febrile noeutropenic episodes were classified as fever of unknown origin (FUO), clinically or microbiolgically documented infection. FUO was defined as fever without any focus or etiology identified by clinical history, physical examination, radiological or microbiologic testing 10 . The diagnosis of microbiologically documented infection was based on both isolation and a causative organism from body fluids. Clinically documented infection was defined as there was evidence of focal inflammation on physical examination but without microbiological confirmation 11 .
The first line antibiotic (empirical) treatments were started at the beginning of fever period in all children. First line antibiotic treatment included; cefepim or ceftazidime alone, cefepim, ceftazidime or cefaperazon-sulbactam with amikacin or carbapenem alone. If the fever persist after ≥ 48-72 hours of empirical treatment, or children had gram (+) bacteria isolated from hemoculture, glycopepetid was started as a second line treatment. After 4-5 days, if fever did not settle then either glycopeptid was added or if there was suspicion of fungal infection, antifungal therapy was started as a third line therapy. were the most common identifed infection foci (Table II) .
Results

A total of
Sixty eight (50%) of febrile episodes were documented microbiologically. Bacterial documentation was made by hemoculture in 44 (32.4%), by urine culture in 14 (10.3%), by skin lesion culture in 10 (7.4%) of febrile episodes. In 28 (63.8 %) of the 44 febrile episodes gram (+) bacteria were isolated in hemoculture. Gram (-) bacteria were isolated in 9 episodes (20.5%), and fungus were isolated in 7 episodes (15.9%). The distribution of bacteria isolated from hemoculture were shown in Table III .
Skin lesion culture were made in 13 of febrile episodes. Microroganisms were isolated in 10 of these cultures. Microorganism isolated from skin lesion cultures and infection focus presented in Table IV (Table V) .
Second line therapy was used in 23 of febrile episodes. Glycopeptide (teicoplanin) agent combination with ceftazidime+amikacin in 9 (1 child died), combination with cefepime+amikacin in 3, combination with carbapenem in 11 ( 2 children died) of febrile episodes (Table VI) .
Third line therapy was used in 15 of febrile episodes. Antifungal agent (amphotericin B) combination with ceftazidime+amikacin in 7 (1 child died) and combination with carbapenem in 8 (4 children died) of febrile episodes (Table VI) . In this study, antibiotic treatment outcomes in overall treatment 21 showed that gram (+) bacteria are more frequently causative agents. In the present study the most commonly isolated agents were gram (+) bacteria (63.8%). Among the gram positives Methicillin-sensitive Staphylococcus aureus (MSSA) were the predominant pathogens (20.5%) of febrile episodes (Table III) .
In our study, we found the most common infection site was oral cavitiy and catheter entry site infections of which documented gram (+) bacteria by hemoculture. These results may be related to inadequate care and hygienic problems of our patients. According to the literature, such things as growing use of indwelling venous catheters and oral mucositis are risk factors for gram (+) infections in febrile neutropenic patients 22, 23 . Our data also supported these investigations.
Several studies have reported that 24% to 55% of febrile episodes are fever of unknown origin 24, 25 . International Antimicrobial Therapy Cooperative Group-European Organization for Research and Treatment of Cancer (IATCG-EORTC) have reported microbiological documentation in about 27% of the febrile patients 26 . In our study, 68 (50%) of febrile episodes were microbiologically documented which causes infection in neutropenic children. About 44 (32.4%) of these episodes were associated with bacteremia. We were able to find that microbiologically documentation in this study may be associated with several factor, such as, their parents have low levels education, majority of parents could not make the measurement of fever and not admitted the hospital early time and our patients do not receive of antibacterial prophylaxis.
In our study 47 (35%) of febrile episodes were clinically documented infections. The findings about source of infection seemed to be various. Some studies reported that most common site was respiratory tract 27,28 . Güneş et al. 10 and Saanboonrat et al. 16 found that the most common infection source was oral cavity. Oral mucositis and respiraory tract infections have similar proportions as the most frequent foci of infection were identified in our study (Table II) .
With improved treatment and better survival from bacterial infections in febrile neutropenic patients, prevention and treatment of fungal infections have assumed greater importance, especially in patients with prolonged neutropenia. These infections tend to occur as secondary infections, rarely being identified at the onset of a febrile episode. Most fungal infections in children with cancer are caused by C. albicans accounting for most isolates. In recent years, an increase in prevalance of other Candida species such as C. glabrata, and C. crusei have become more common. However, C. albicans are still more frequent in many institutions 29 . In our study the incidence of microbiologically proven fungal infections were found in 15.9%, although most isolated fungal agents were C. albicans.
In our study, the response rate was comparable to those of other beta-lactam-aminoglycoside regimens tested in such a pediatric population. In a prospective non-comparative open study of piperacillin plus gentamicin for the treatment In our study, an overall response rate of 70.5% was achieved by the first-line treatment. These results suggested that ceftazidim plus amikacin therapy is effective in our neutropenic patients.
In conclusion, we suggest that complete physical examination which skin, mucous membranes, and sinuses should be done. Recommended initial treatment should be considered as guidelines, but alterations could be based on the predominant organisms isolated from patient population of each hospital. In this study we report the frequency of isolated microroganisms and infection site in our hematology clinic. Our study to was the first study to evaluate febrile episodes in neutropenic children in Southeast Anatolia.
